This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1985 Feb;69(2):231-3.

Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study

F E Bull, D D Von Hoff, S P Balcerzak, R L Stephens, F J Panettiere

PMID: 3882233

Clinical Trial

Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study

F E Bull et al. Cancer Treat Rep. 1985 Feb.

. 1985 Feb;69(2):231-3.

Authors

F E Bull, D D Von Hoff, S P Balcerzak, R L Stephens, F J Panettiere

PMID: 3882233

No abstract available

PubMed Disclaimer

Similar articles

Treatment of metastatic sarcomas with mitoxantrone.
Presant CA, Gams R, Bartolucci AA. Presant CA, et al. Cancer Treat Rep. 1984 May;68(5):813-4. Cancer Treat Rep. 1984. PMID: 6722837 No abstract available.
Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Taylor SA, Von Hoff DD, Baker LH, Balcerzak SP. Taylor SA, et al. Cancer Treat Rep. 1984 Jun;68(6):919-20. Cancer Treat Rep. 1984. PMID: 6733708 Clinical Trial. No abstract available.
Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
DeSimone PA, Gams R, Birch R. DeSimone PA, et al. Cancer Treat Rep. 1986 Aug;70(8):1043-4. Cancer Treat Rep. 1986. PMID: 3524836 Clinical Trial. No abstract available.
Mitoxantrone (novantrone): a review of experimental and early clinical studies.
Smith IE. Smith IE. Cancer Treat Rev. 1983 Jun;10(2):103-15. doi: 10.1016/0305-7372(83)90008-7. Cancer Treat Rev. 1983. PMID: 6347376 Review. No abstract available.
Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Demetri GD, Elias AD. Demetri GD, et al. Hematol Oncol Clin North Am. 1995 Aug;9(4):765-85. Hematol Oncol Clin North Am. 1995. PMID: 7490240 Review.

See all similar articles

Cited by

Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group.
Nielsen OS, Dombernowsky P, Mouridsen H, Daugaard S, Van Glabbeke M, Kirkpatrick A, Verweij J. Nielsen OS, et al. Sarcoma. 2000;4(1-2):31-5. doi: 10.1155/S1357714X00000062. Sarcoma. 2000. PMID: 18521432 Free PMC article.
Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas.
Stroppa E, Bertuzzi A, Di Comite G, Mussi C, Lutman RF, Barbato A, Santoro A. Stroppa E, et al. Invest New Drugs. 2010 Dec;28(6):834-8. doi: 10.1007/s10637-009-9288-7. Epub 2009 Jul 7. Invest New Drugs. 2010. PMID: 19582371 Clinical Trial.
Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.
Faulds D, Balfour JA, Chrisp P, Langtry HD. Faulds D, et al. Drugs. 1991 Mar;41(3):400-49. doi: 10.2165/00003495-199141030-00007. Drugs. 1991. PMID: 1711446 Review.
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Nielsen OS, Dombernowsky P, Mouridsen H, Crowther D, Verweij J, Buesa J, Steward W, Daugaard S, van Glabbeke M, Kirkpatrick A, Tursz T. Nielsen OS, et al. Br J Cancer. 1998 Dec;78(12):1634-9. doi: 10.1038/bjc.1998.735. Br J Cancer. 1998. PMID: 9862576 Free PMC article. Clinical Trial.
Leiomyosarcoma of the great saphenous vein.
Saglik Y, Icli F, Uluoglu O, Isiklar ZU. Saglik Y, et al. Int Orthop. 1992;16(2):185-7. doi: 10.1007/BF00180214. Int Orthop. 1992. PMID: 1428321

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

etc

LinkOut - more resources

Medical
- MedlinePlus Health Information